Pradaxa Settlement Negotiations Planned

The first federal Pradaxa trials are set to begin in 2014, and lawyers involved in these cases are slated to meet to discuss potential settlement agreements later this year.

Boehringer Ingelheim is the subject of multiple Pradaxa lawsuits in the United States.  These suits are based on claims that the drug maker failed to provide adequate warning about Pradaxa internal bleeding side effects.  Plaintiffs also claim that they were not properly warned about the lack of a reversal agent to stop Pradaxa hemorrhages.

All federal Pradaxa lawsuits have been consolidated for pretrial proceedings before U.S. District Judge David R. Herndon in the Southern District of Illinois.

Each side of the Pradaxa MDL has been ordered by Judge Herndon to designate settlement counsel by July 1, 2012.  As of August 2013, both sides must meet at least once per month to discuss potential settlement agreements with the help of a designated mediator, allowing one year for negotiation before the first bellwether trials start.

If no settlement is reached, four bellwether trials will be held between August 2014 and February 2015.  During these early trials, both parties will be able to gauge how juries may respond to specific evidence and testimony.  Results of these trials may also help the parties reach a settlement agreement.

Pradaxa (dabigitran) was introduced by Boehringer Ingelheim in October 2010.  It is an anticoagulant, or blood thinner, prescribed to prevent blood clots and strokes in patients with atrial fibrillation.

Though Pradaxa has been promoted as superior to warfarin (Coumadin), internal bleeding in warfarin patients can be stopped with a dose of Vitamin K and there is no such reversal agent for Pradaxa bleeding.

At least 120 federal Pradaxa lawsuits have been included in the MDL presided over by Judge Herndon.  This type of consolidation is common in dangerous drug lawsuits that involve a large number of claims surrounding the same medication.  Consolidation helps prevent duplicate discovery and is more convenient for all parties involved.

Contact a Pradaxa Lawyer

If you or someone you love has suffered internal bleeding or hemorrhaging after taking Pradaxa, you may be entitled to compensation.  Contact a qualified personal injury lawyer to become educated about your rights in a free consultation.


Feb. 4, 2013 | Tags: Dangerous Drugs, Pradaxa

View All Legal News